<?xml version="1.0" encoding="UTF-8"?>
<p id="Par21">In India to 3 out of 4 patients were treated in Jaipur at Sawai Man Sing Hospital by the combination of Lopinavir/Ritonavir (used against HIV), chloroquine (anti-malarial) and oseltamivir drugs (treat swine flu) [
 <xref ref-type="bibr" rid="CR26">26</xref>]. Now the researcher has moved to plasma therapy against critical condition and looking for the in vitro effect of leprosy drug. Plasma therapy is not a new attempt rather it has been used against many viral infections like hepatitis B, rabies and varicella zoster viruses. It was also proved effective against SARS [
 <xref ref-type="bibr" rid="CR3">3</xref>]. Looking at the similarity index of COVID-19 with SARS many countries has approved the clinical trial of plasma therapy. In this process plasma is isolated from covid history patient with age &gt; 18 and transfused intravenously to Covid-19 patient. Though the result is still under analysis and even if it will be successful then it is difficult to meet the desired demand [
 <xref ref-type="bibr" rid="CR19">19</xref>]. Though many steps have been taken and are in progress but yet not fully successful. So, it is better defined to prevent instead of waiting to be cured.
</p>
